- Home
- TELO vs NOTE Comparison
TELO vs NOTE Comparison
Compare TELO & NOTE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TELO
- NOTE
- Stock Information
- Founded
- TELO 2021
- NOTE 2013
- Country
- TELO United States
- NOTE United States
- Employees
- TELO N/A
- NOTE N/A
- Industry
- TELO
- NOTE EDP Services
- Sector
- TELO
- NOTE Technology
- Exchange
- TELO NYSE
- NOTE Nasdaq
- Market Cap
- TELO 124.1M
- NOTE 132.5M
- IPO Year
- TELO 2024
- NOTE N/A
- Fundamental
- Price
- TELO $3.73
- NOTE $0.80
- Analyst Decision
- TELO
- NOTE Strong Buy
- Analyst Count
- TELO 0
- NOTE 7
- Target Price
- TELO N/A
- NOTE $3.30
- AVG Volume (30 Days)
- TELO 61.7K
- NOTE 579.3K
- Earning Date
- TELO 11-12-2024
- NOTE 11-12-2024
- Dividend Yield
- TELO N/A
- NOTE N/A
- EPS Growth
- TELO N/A
- NOTE N/A
- EPS
- TELO N/A
- NOTE N/A
- Revenue
- TELO N/A
- NOTE $125,062,000.00
- Revenue This Year
- TELO N/A
- NOTE N/A
- Revenue Next Year
- TELO N/A
- NOTE $7.25
- P/E Ratio
- TELO N/A
- NOTE N/A
- Revenue Growth
- TELO N/A
- NOTE N/A
- 52 Week Low
- TELO $3.11
- NOTE $0.74
- 52 Week High
- TELO $20.72
- NOTE $2.27
- Technical
- Relative Strength Index (RSI)
- TELO 35.99
- NOTE 28.39
- Support Level
- TELO $4.11
- NOTE $0.77
- Resistance Level
- TELO $4.54
- NOTE $0.98
- Average True Range (ATR)
- TELO 0.33
- NOTE 0.09
- MACD
- TELO -0.01
- NOTE -0.01
- Stochastic Oscillator
- TELO 5.36
- NOTE 17.29
About TELO TELOMIR PHARMACEUTICALS INC
Telomir Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical company focused on the development and commercialization of TELOMIR-1, a novel small molecule being developed to function as an oral in situ therapeutic treatment for human stem cells.
About NOTE FiscalNote Holdings Inc.
FiscalNote Holdings Inc is a provider of global policy and market intelligence solutions. Leveraging AI and analytics, it delivers actionable legal and policy insights for businesses, government institutions, and nonprofits. Its suite of products includes FiscalNote Core, CQ Federal, and EU Issue Tracker, facilitating effective policy management and risk mitigation. With expert analysis from FrontierView, Oxford Analytica, and Dragonfly Eye, it offers geopolitical and market intelligence services. Operating as one segment, it generates revenue by integrating policy intelligence into daily operations. Geographically the company generates the majority of its revenue from North America, Europe, Australia, and Asia, with the majority generated from North America.